Moderna surges over 600%, projected as top healthcare winner for 2026
JNJ Johnson & Johnson
$259.36 +2.19%
View chart & analysis → - 1Moderna is on track to become the largest healthcare winner among large-cap stocks in 2026 with its share price surging over 600%.
- 2Moderna recorded $534 million in revenue during the first half of 2026 but reported a net loss of $2.1 billion.
- 3The article reports that Moderna's average price target is $123.61 and suggests avoiding the stock at its current level.
So what's the key point?
Moderna's stock price has risen significantly by more than 600%. While experts expect the stock to rise further, they suggest it is better to avoid it at this time.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.